Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -1,504.64%-7.14B | ---- | -151.89%-444.86M | -68.08%180.01M | 141.78%857.32M | 379.45%563.97M | -589.93%-2.05B | 68.07%-201.82M | 90.74%-297.43M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 16.04%-134.6M | ---- | 26.27%-160.32M | ---- | -7.07%-217.43M | ---- | -44.41%-203.07M | ---- | 56.59%-140.63M |
| Dividend (income)- adjustment | ---- | 75.43%-3.71M | ---- | 20.52%-15.11M | ---- | 24.60%-19.01M | ---- | -160.73%-25.21M | ---- | 93.73%-9.67M |
| Attributable subsidiary (profit) loss | ---- | 2,167.42%67.19M | ---- | -104.31%-3.25M | ---- | -94.59%75.4M | ---- | 6,672.81%1.39B | ---- | -88.31%20.58M |
| Impairment and provisions: | ---- | 723.98%7.52B | ---- | 285.70%912.58M | ---- | -243.62%-491.43M | ---- | -78.30%342.17M | ---- | 183.24%1.58B |
| -Impairment of property, plant and equipment (reversal) | ---- | 273.70%234.26M | ---- | -73.84%62.69M | ---- | 191.37%239.6M | ---- | -68.24%82.23M | ---- | 3,134.94%258.89M |
| -Impairmen of inventory (reversal) | ---- | 23.60%77.37M | ---- | -71.24%62.6M | ---- | 31.83%217.63M | ---- | 339.48%165.09M | ---- | 164.27%37.57M |
| -Impairment of trade receivables (reversal) | ---- | --6.63B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 236.42%181.67M |
| -Other impairments and provisions | ---- | -26.43%579.21M | ---- | 182.99%787.29M | ---- | -1,100.18%-948.66M | ---- | -91.37%94.85M | ---- | 98.63%1.1B |
| Revaluation surplus: | ---- | 265.34%506.34M | ---- | -84.91%138.6M | ---- | -48.21%918.59M | ---- | 383.25%1.77B | ---- | -122.65%-626.19M |
| -Fair value of investment properties (increase) | ---- | 521.68%444.34M | ---- | 4,541.23%71.48M | ---- | 103.97%1.54M | ---- | 93.20%-38.77M | ---- | -837.11%-570.04M |
| -Other fair value changes | ---- | -7.63%62M | ---- | -92.68%67.12M | ---- | -49.40%917.05M | ---- | 3,327.72%1.81B | ---- | -101.99%-56.15M |
| Asset sale loss (gain): | ---- | 26.28%-7.16M | ---- | 93.46%-9.71M | ---- | 27.10%-148.47M | ---- | -1,077.90%-203.65M | ---- | 185.66%20.83M |
| -Loss (gain) from sale of subsidiary company | ---- | 125.01%2.57M | ---- | -28.13%-10.28M | ---- | 96.32%-8.03M | ---- | -1,425.48%-217.99M | ---- | 148.36%16.45M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -1,782.87%-9.73M | ---- | 151.47%578K | ---- | 57.49%-1.12M | ---- | -160.33%-2.64M | ---- | -88.89%4.38M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | -920.30%-139.32M | ---- | --16.98M | ---- | ---- |
| Depreciation and amortization: | ---- | 29.77%947.87M | ---- | 17.92%730.42M | ---- | -5.87%619.4M | ---- | 4.05%658.04M | ---- | -6.55%632.42M |
| -Depreciation | ---- | 32.67%830.96M | ---- | 23.70%626.33M | ---- | -1.27%506.34M | ---- | 5.71%512.84M | ---- | -10.12%485.13M |
| -Amortization of intangible assets | ---- | -0.16%70.31M | ---- | 0.73%70.42M | ---- | -1.53%69.91M | ---- | -2.91%71M | ---- | -14.68%73.12M |
| -Other depreciation and amortization | ---- | -76.38%-69.67M | ---- | -129.41%-39.5M | ---- | 30.98%-17.22M | ---- | 0.68%-24.95M | ---- | 11.50%-25.12M |
| Financial expense | ---- | -12.11%997.69M | ---- | 29.29%1.14B | ---- | 81.99%877.97M | ---- | -20.26%482.44M | ---- | -26.87%605M |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | -427.61%-191.83M | ---- | 219.39%58.55M | ---- | 1,526.71%18.33M |
| Unrealized exchange loss (gain) | ---- | -36.43%-168.46M | ---- | ---123.48M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items | ---- | ---- | ---- | -47.27%38.87M | 55.77%-105.98M | --73.71M | -135.19%-239.64M | ---- | -56.35%680.89M | --547.67M |
| Adjustment items | ---- | -76.38%-69.67M | ---- | -129.41%-39.5M | ---- | 30.98%-17.22M | ---- | 0.68%-24.95M | ---- | 11.50%-25.12M |
| Operating profit before the change of operating capital | ---- | 16.54%2.52B | ---- | -7.60%2.16B | -77.18%74.02M | 6.23%2.34B | -32.30%324.33M | -5.29%2.2B | -48.36%479.07M | 84.71%2.32B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 29.07%415.08M | ---- | 116.58%321.61M | ---- | -16.10%-1.94B | ---- | -44.55%-1.67B | ---- | -566.96%-1.16B |
| Developing property (increase)decrease | ---- | -35.86%2.5M | ---- | 108.40%3.89M | ---- | 2,264.56%1.87M | ---- | -99.91%79K | ---- | -16.45%92.29M |
| Accounts receivable (increase)decrease | ---- | -863.36%-4.74B | ---- | 115.08%621.29M | ---- | -257.53%-4.12B | ---- | 49.20%-1.15B | ---- | -277.94%-2.27B |
| Accounts payable increase (decrease) | ---- | 192.23%1.98B | ---- | -148.54%-2.14B | ---- | 672.04%4.41B | ---- | -149.82%-771.44M | ---- | 899.06%1.55B |
| Special items for working capital changes | ---- | -154.41%-96.4M | ---- | -53.09%177.18M | ---- | -50.57%377.74M | ---- | 21.17%764.14M | ---- | 321.46%630.62M |
| Cash from business operations | 247.71%1.09B | -93.82%70.51M | -1,096.61%-737.71M | 6.67%1.14B | -77.18%74.02M | 269.73%1.07B | -32.30%324.33M | -153.88%-630.52M | -48.36%479.07M | -51.74%1.17B |
| Other taxs | -21.70%-142.93M | 47.80%-185.18M | 39.58%-117.45M | -1.94%-354.76M | -13.75%-194.39M | 14.97%-347.99M | 30.65%-170.89M | -35.03%-409.24M | -5,713.44%-246.43M | -393.71%-303.07M |
| Net cash from operations | 210.71%946.72M | -114.57%-114.67M | -610.43%-855.15M | 8.95%786.79M | -178.45%-120.37M | 169.46%722.17M | -34.04%153.44M | -219.90%-1.04B | -75.05%232.64M | -63.31%867.21M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -25.20%56.19M | -19.39%131.33M | -7.23%75.11M | -40.31%162.93M | -53.40%80.96M | 251.90%272.94M | 244.36%173.76M | -9.51%77.56M | -2.46%50.46M | -59.96%85.71M |
| Dividend received - investment | -24.58%2.17M | -0.97%2.87M | -0.97%2.87M | --2.9M | --2.9M | ---- | ---- | --50M | ---- | ---- |
| Loan receivable (increase) decrease | ---- | -86.31%6M | 103.47%4M | -93.13%43.84M | -121.85%-115.24M | -29.06%637.68M | -42.01%527.29M | 40.10%898.86M | 55.62%909.22M | 241.07%641.56M |
| Decrease in deposits (increase) | -2,539.84%-485.75M | -43.69%751.63M | -89.86%19.91M | 144.50%1.33B | 111.27%196.25M | -1,128.13%-3B | -13.60%-1.74B | -122.88%-244.25M | -9,735.46%-1.53B | 409.66%1.07B |
| Sale of fixed assets | -95.16%1.26M | 42.21%105.34M | 612.31%26.04M | 276.47%74.07M | -69.03%3.66M | -42.46%19.68M | -30.98%11.8M | -54.69%34.19M | -7.39%17.1M | 162.49%75.46M |
| Purchase of fixed assets | 53.26%-633.68M | 15.41%-2.09B | 14.91%-1.36B | 5.92%-2.47B | -37.92%-1.59B | -135.44%-2.62B | -82.49%-1.16B | -95.05%-1.11B | -173.26%-633.14M | 31.57%-571.23M |
| Purchase of intangible assets | ---- | 9.09%-50.75M | 18.28%-45.62M | -168.31%-55.83M | -168.31%-55.83M | 50.40%-20.81M | ---20.81M | -224.60%-41.95M | ---- | 85.15%-12.92M |
| Sale of subsidiaries | ---18K | -20.37%31.73M | ---- | -70.99%39.84M | --11.5M | -22.45%137.35M | ---- | 110.21%177.1M | 62.98%121.91M | -47.99%84.25M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | -3,048.28%-6.84M | ---6.84M | 100.06%232K | ---- | -554.44%-394.24M |
| Recovery of cash from investments | ---- | -73.19%74.18M | -41.44%57.84M | -44.85%276.68M | -86.45%98.78M | -49.14%501.64M | 21.46%728.88M | -52.09%986.25M | -33.07%600.1M | 1.37%2.06B |
| Cash on investment | ---- | 78.25%-35M | ---- | 90.85%-160.92M | ---- | -10.93%-1.76B | 82.82%-111.78M | -81.40%-1.59B | -630.27%-650.73M | -127.13%-873.74M |
| Other items in the investment business | -71.16%80.42M | 36.67%343.21M | 31.33%278.88M | 26.39%251.13M | 131.12%212.35M | -1.25%198.7M | -521.68%-682.45M | -12.97%201.22M | -0.61%161.84M | -52.73%231.21M |
| Net cash from investment operations | -4.54%-979.41M | -45.84%-727.04M | 19.11%-936.84M | 91.16%-498.52M | 49.13%-1.16B | -907.34%-5.64B | -138.14%-2.28B | -123.41%-559.98M | -190.76%-956.1M | 82.22%2.39B |
| Net cash before financing | 98.18%-32.69M | -391.99%-841.71M | -40.16%-1.79B | 105.86%288.27M | 39.79%-1.28B | -207.47%-4.92B | -193.51%-2.12B | -149.08%-1.6B | -136.43%-723.46M | -11.34%3.26B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -32.23%2.79B | -14.58%6.99B | -7.75%4.12B | -14.93%8.19B | -21.51%4.46B | 50.48%9.62B | 82.30%5.68B | 14.80%6.39B | 8.75%3.12B | 0.62%5.57B |
| Refund | -3.44%-2.47B | -8.13%-7.19B | 18.49%-2.39B | -9.50%-6.65B | 24.34%-2.93B | -42.65%-6.07B | -65.93%-3.87B | 29.77%-4.25B | 13.79%-2.33B | 25.61%-6.06B |
| Issuing shares | ---- | ---- | ---- | -72.22%173.39M | ---- | --624.13M | --252.29M | ---- | ---- | ---- |
| Interest paid - financing | 44.87%-235.96M | 30.42%-602.67M | -29.42%-428.02M | -27.20%-866.14M | -5.09%-330.71M | -38.51%-680.94M | -18.17%-314.68M | 21.29%-491.63M | 10.07%-266.29M | 17.62%-624.61M |
| Dividends paid - financing | ---- | ---102.08M | ---- | ---- | ---- | -29,567.33%-89M | ---- | 99.61%-300K | ---- | -155.41%-76.63M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --150M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -53,598.85%-2.43B |
| Other items of the financing business | -55.47%9.39M | 70.82%19.94M | 126.67%21.09M | -99.54%11.67M | -99.62%9.3M | 163.05%2.51B | 146.12%2.46B | 2,000.05%955M | --1B | -176.39%-50.26M |
| Net cash from financing operations | -94.10%77.67M | -205.39%-898.42M | 9.15%1.32B | -85.55%852.47M | -71.23%1.21B | 126.61%5.9B | 180.47%4.19B | 173.99%2.6B | 232.01%1.49B | -2.91%-3.52B |
| Effect of rate | 189.84%8.45M | -40.74%11.43M | -93.36%2.91M | -76.15%19.3M | 13.81%43.91M | 490.57%80.89M | 1,121.31%38.59M | 56.51%-20.71M | -133.64%-3.78M | -1,908.62%-47.62M |
| Net Cash | 109.45%44.98M | -252.54%-1.74B | -552.42%-476.12M | 16.42%1.14B | -103.53%-72.98M | -2.34%979.82M | 168.22%2.07B | 487.63%1B | -9.75%770.8M | -200.48%-258.81M |
| Begining period cash | -30.36%3.97B | 25.59%5.69B | 25.59%5.69B | 30.54%4.53B | 30.54%4.53B | 39.45%3.47B | 39.45%3.47B | -10.96%2.49B | -10.96%2.49B | 10.26%2.8B |
| Cash at the end | -23.03%4.02B | -30.36%3.97B | 15.89%5.22B | 25.59%5.69B | -19.26%4.5B | 30.54%4.53B | 71.27%5.58B | 39.45%3.47B | -11.05%3.26B | -10.96%2.49B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.